NasdaqGM - Nasdaq Real Time Price USD
ARS Pharmaceuticals, Inc. (SPRY)
14.69
-0.31
(-2.07%)
As of 1:06:08 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
13,548
13,548
-59,266
-40,078
-17,561
Investing Cash Flow
-106,101
-106,101
-87,180
-199
-55
Financing Cash Flow
72,399
72,399
6,899
190,732
53,158
End Cash Position
50,817
50,817
70,971
210,518
60,063
Interest Paid Supplemental Data
--
--
--
366
576
Capital Expenditure
-563
-563
-175
-199
-55
Issuance of Capital Stock
--
--
--
--
54,806
Repayment of Debt
--
--
--
-8,681
-1,817
Free Cash Flow
12,985
12,985
-59,441
-40,277
-17,616
12/31/2021 - 12/4/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASND Ascendis Pharma A/S
158.48
-0.41%
SWTX SpringWorks Therapeutics, Inc.
40.87
+0.91%
ARQT Arcutis Biotherapeutics, Inc.
14.48
+4.66%
VRNA Verona Pharma plc
63.61
+2.57%
TARS Tarsus Pharmaceuticals, Inc.
49.98
+1.08%
TVTX Travere Therapeutics, Inc.
16.96
+6.80%
MTSR Metsera, Inc.
23.41
+7.98%
CYTK Cytokinetics, Incorporated
38.73
+2.43%
ETNB 89bio, Inc.
6.80
+3.82%
MIST Milestone Pharmaceuticals Inc.
1.1600
+9.43%